Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Increased strontium uptake in trabecular bone of ovariectomized calcium-deficient rats treated with strontium ranelate or strontium chloride.

Pemmer B, Hofstaetter JG, Meirer F, Smolek S, Wobrauschek P, Simon R, Fuchs RK, Allen MR, Condon KW, Reinwald S, Phipps RJ, Burr DB, Paschalis EP, Klaushofer K, Streli C, Roschger P.

J Synchrotron Radiat. 2011 Nov;18(Pt 6):835-41. doi: 10.1107/S090904951103038X. Epub 2011 Sep 15.

PMID:
21997907
2.

Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment.

Roschger P, Manjubala I, Zoeger N, Meirer F, Simon R, Li C, Fratzl-Zelman N, Misof BM, Paschalis EP, Streli C, Fratzl P, Klaushofer K.

J Bone Miner Res. 2010 Apr;25(4):891-900. doi: 10.1359/jbmr.091028.

3.

Strontium ranelate in osteoporosis.

Reginster JY.

Curr Pharm Des. 2002;8(21):1907-16. Review.

PMID:
12171530
4.

Strontium ranelate does not stimulate bone formation in ovariectomized rats.

Fuchs RK, Allen MR, Condon KW, Reinwald S, Miller LM, McClenathan D, Keck B, Phipps RJ, Burr DB.

Osteoporos Int. 2008 Sep;19(9):1331-41. doi: 10.1007/s00198-008-0602-6. Epub 2008 Apr 3.

PMID:
18385919
5.

Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment.

Li C, Paris O, Siegel S, Roschger P, Paschalis EP, Klaushofer K, Fratzl P.

J Bone Miner Res. 2010 May;25(5):968-75. doi: 10.1359/jbmr.091038.

6.

Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants.

Bain SD, Jerome C, Shen V, Dupin-Roger I, Ammann P.

Osteoporos Int. 2009 Aug;20(8):1417-28. doi: 10.1007/s00198-008-0815-8. Epub 2008 Dec 19.

PMID:
19096745
7.

Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats.

Ammann P, Shen V, Robin B, Mauras Y, Bonjour JP, Rizzoli R.

J Bone Miner Res. 2004 Dec;19(12):2012-20. Epub 2004 Sep 13. Erratum in: J Bone Miner Res. 2005 Mar;20(3):548.

8.

Long-term strontium ranelate administration in monkeys preserves characteristics of bone mineral crystals and degree of mineralization of bone.

Farlay D, Boivin G, Panczer G, Lalande A, Meunier PJ.

J Bone Miner Res. 2005 Sep;20(9):1569-78. Epub 2005 Apr 27.

9.

No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.

Anastasilakis AD, Goulis DG, Polyzos SA, Gerou S, Ballaouri I, Efstathiadou Z, Kita M, Avramidis A.

Clin Endocrinol (Oxf). 2009 Apr;70(4):522-6. doi: 10.1111/j.1365-2265.2008.03342.x.

PMID:
18625000
10.

Strontium is incorporated in different levels into bones and teeth of rats treated with strontium ranelate.

Oliveira JP, Querido W, Caldas RJ, Campos AP, Abraçado LG, Farina M.

Calcif Tissue Int. 2012 Sep;91(3):186-95. doi: 10.1007/s00223-012-9625-2. Epub 2012 Jul 18.

PMID:
22806682
11.

Compositional and material properties of rat bone after bisphosphonate and/or Strontium ranelate drug treatment.

Wu Y, Adeeb SM, Duke MJ, Munoz-Paniagua D, Doschak MR.

J Pharm Pharm Sci. 2013;16(1):52-64.

12.

Strontium ranelate: a new paradigm in the treatment of osteoporosis.

Reginster JY, Deroisy R, Jupsin I.

Drugs Today (Barc). 2003 Feb;39(2):89-101. Review.

PMID:
12698204
13.

Improvement in bone strength parameters. The role of strontium ranelate.

Tournis S.

J Musculoskelet Neuronal Interact. 2007 Jul-Sep;7(3):266-7. Review.

14.

Effect of long-term treatment with strontium ranelate on bone strontium content.

Bärenholdt O, Kolthoff N, Nielsen SP.

Bone. 2009 Aug;45(2):200-6. doi: 10.1016/j.bone.2009.04.196. Epub 2009 Apr 17.

PMID:
19376283
15.
16.

Trabecular reorganization in consecutive iliac crest biopsies when switching from bisphosphonate to strontium ranelate treatment.

Jobke B, Burghardt AJ, Muche B, Hahn M, Semler J, Amling M, Majumdar S, Busse B.

PLoS One. 2011;6(8):e23638. doi: 10.1371/journal.pone.0023638. Epub 2011 Aug 16.

17.
18.

Strontium ranelate: vertebral and non-vertebral fracture risk reduction.

Seeman E.

Curr Opin Rheumatol. 2006 Jun;18 Suppl 1:S17-20.

PMID:
16735841
19.

Efficacy of strontium ranelate on bone mineral density in men with osteoporosis.

Ringe JD, Dorst A, Farahmand P.

Arzneimittelforschung. 2010;60(5):267-72.

PMID:
20533764
20.

The effect of PTH(1-84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial.

Quesada-Gómez JM, Muschitz C, Gómez-Reino J, Greisen H, Andersen HS, Dimai HP.

Osteoporos Int. 2011 Sep;22(9):2529-37. doi: 10.1007/s00198-010-1460-6. Epub 2010 Oct 30.

PMID:
21052638

Supplemental Content

Support Center